Debating the risks of drug-eluting stents.
Shuchman
Miriam
M
D026683:Advisory Committees; D015906:Angioplasty, Balloon, Coronary; D023903:Coronary Restenosis / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000209:etiology*; D018795:Device Approval; D016503:Drug Delivery Systems / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D010975:Platelet Aggregation Inhibitors